Mata Chinnmastika Pharma Llp - Due diligence report

A 360° intelligence report on Mata Chinnmastika Pharma Llp: trust score, financial health, credit view, compliance, directors, growth and di…

2022-10-07 Mullanpur, Punjab Active
Connect MCP
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Mata Chinnmastika Pharma Llp — 360° Intelligence Report

Generated from MCA filings & public records
84/100
Trust Score
Low Risk

Mata Chinnmastika Pharma Llp is assessed as Low Risk with a Trust Score of 84/100. Mata Chinnmastika Pharma Llp is an active limited liability partnership incorporated in 2022, operating in the Paper sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a low compliance risk and an unassessed financial risk profile.

Report generated on 16 Oct 2026 from the latest processed filings. Mata Chinnmastika Pharma Llp snapshot & full profile →

Financial Health › No Data
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
84/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
88/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreNo Data
N/A
No processed financial statements available yet.
Credit Risk ScoreNo Data
N/A
Financial statements needed for a credit view.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreNo Data
N/A
Needs at least two filed years to measure growth.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

No processed financials
Financial statements are not yet processed for this company. Trend analysis will appear once filings are available.
04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: N/A No Data
  • Financial statements needed for a credit view.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 88/100 Low Risk
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2025).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
AMARJIT KAUR ARORA 01234567 Director 01/04/2018 6 yrs Approved
NAVPREET KAUR 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
06

Ownership & Group Intelligence

Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth N/A · Distress 90
Growth signals & trust indicators
Young company (4 years).
Financials unavailable - score leans on compliance and governance signals.
Distress signals & risk flags
No critical warning flags detected in the available data.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence87/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • No financials on record - ask for audited statements.
Banker assessment77/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • No filed financials - rely on banking statements and GST data.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view64/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Request management accounts - public filings insufficient.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 5 events
31 Mar 2025
Last AGM held
Annual general meeting
Latest balance sheet
Filed with ROC
07 Oct 2022
Incorporated
Registered with Roc Chandigarh
Director appointed
AMARJIT KAUR ARORA (Designated Partner)
Director appointed
NAVPREET KAUR (Designated Partner)
10

Key Observations

Auto-generated from the data above
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); board looks stable and experienced.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Wuds Media Private Limited U74999PB2017PTC046033 Rupnagar, Punjab
Medineel Pharma Private Limited U51909PB2021PTC052665 Rupnagar, Punjab
Competent Syntech Private Limited U74900PB2011PTC035068 Rupnagar, Punjab
Bitfireone Private Limited U58203PB2024PTC062575 Rupnagar, Punjab
Ray Noya Private Limited U62013PB2023PTC058951 Rupnagar, Punjab
Konsol Education And Immigration Consult Ants Private Limited U74999PB2008PTC031769 Rupnagar, Punjab
Hsp Transport And Services Private Limited U52290PB2024PTC062102 Rupnagar, Punjab
Apcos Naturals Private Limited U74999PB2018PTC048652 Rupnagar, Punjab
Burfi Music Private Limited U92490PB2020PTC051184 Rupnagar, Punjab
BOUTIQUERY ONLINE LLP AAW-2037 Rupnagar, Punjab
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Mata Chinnmastika Pharma Llp before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Mata Chinnmastika Pharma Llp: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score pending financials, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score n/a, margin trends, ownership structure and peer set for Mata Chinnmastika Pharma Llp - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 84/100, distress signals and MSME payment-delay disclosures - know whether Mata Chinnmastika Pharma Llp pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Mata Chinnmastika Pharma Llp - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Mata Chinnmastika Pharma Llp an active company?

Mata Chinnmastika Pharma Llp has MCA status “Active” with a compliance score of 88/100 (Low Risk).

Is Mata Chinnmastika Pharma Llp financially healthy?

Processed financial statements are not yet available for Mata Chinnmastika Pharma Llp, so its financial health is unassessed.

Should I do business with Mata Chinnmastika Pharma Llp?

Its overall Trust Score is 84/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Mata Chinnmastika Pharma Llp?

See the directors and ownership sections above for board and shareholding detail. 2 active director(s) are on record.

Does Mata Chinnmastika Pharma Llp have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Mata Chinnmastika Pharma Llp up to date with its ROC filings?

Balance sheet slightly behind (Mar 2025). Overall compliance score: 88/100 (Low Risk).

Is it risky to lend to Mata Chinnmastika Pharma Llp?

Filed financial statements are needed for a credit view - ask the company for audited statements and bank statements.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.